Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
93
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction

Yang-Yang He1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Yu Yan1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Hui-Fang Zhang1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Yi-Huang Lin3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Yu-Cai Chen1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Yi Yan4 Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
,
Ping Wu1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
,
Jian-Song Fang5 Institute of Clinical Pharmacology, Guangzhou University of Traditional Chinese Medicine, Guangzhou, People’s Republic of China
,
Shu-Hui Yang2 State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
&
Guan-Hua Du1 Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;3 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, BeijingCorrespondence[email protected]
 show all
Pages 3183-3196 | Published online: 29 Sep 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhiqing Zhong, Hongyan Li, Hongzhen Zhong & Tianbiao Zhou. (2019) Clinical efficacy and safety of rituximab in lupus nephritis. Drug Design, Development and Therapy 13, pages 845-856.
Read now
Tianbiao Zhou, Shujun Lin, Shen Yang & Wenshan Lin. (2019) Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis. Drug Design, Development and Therapy 13, pages 857-869.
Read now

Articles from other publishers (6)

Sara Hosseini, Mahmoud Mahmoudi, Zahra Rezaieyazdi, Abbas Shapouri-Moghaddam, Akram Hosseinzadeh, Fahimeh Lavi Arab, Nafiseh Sadat Tabasi & Seyed-Alireza Esmaeili. (2024) Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome. International Immunopharmacology 126, pages 111306.
Crossref
Akram Hoseinzadeh, Zahra Rezaieyazdi, Mahmoud Mahmoudi, Jalil Tavakol Afshari, Fahimeh Lavi Arab, Seyed-Alireza Esmaeili, Arezoo Faridzadeh, Amin Rezaeian, Sara Hoseini, Mehdi Barati, Ali Mahmoudi & Nafiseh Sadat Tabasi. (2023) Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?. International Immunopharmacology 117, pages 109699.
Crossref
Yang Yun, Xuejiao Wang, Jingyi Xu, Chenye Jin, Jingyu Chen, Xueru Wang, Jianing Wang, Ling Qin & Pingting Yang. (2023) Pristane induced lupus mice as a model for neuropsychiatric lupus (NPSLE). Behavioral and Brain Functions 19:1.
Crossref
Yu-Jiao Wang, Ya-Xin Li, Shuo Li, Wei He, Zi-Rui Wang, Tian-Peng Zhan, Chao-Yue Lv, Ying-Ping Liu, Yang Yang & Xiao-Xi Zeng. (2022) Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis. Biomedicine & Pharmacotherapy 149, pages 112799.
Crossref
Thaís Evelyn Karnopp, Gustavo Flores Chapacais, Eduarda Correa Freitas & Odirlei André Monticielo. (2020) Lupus animal models and neuropsychiatric implications. Clinical Rheumatology 40:7, pages 2535-2545.
Crossref
Eduarda Correa Freitas, Mayara Souza de Oliveira & Odirlei André Monticielo. (2017) Pristane-induced lupus: considerations on this experimental model. Clinical Rheumatology 36:11, pages 2403-2414.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.